Sign in

CIK 0001077183

  • Large accelerated filer

NEOGENOMICS INC

Sign in to watch
Ticker
NEO
Exchange
Nasdaq
Industry
Services-Testing Laboratories
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
742897368
Phone
+1 239-768-0600
Business address
9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912
Former names
AMERICAN COMMUNICATIONS ENTERPRISES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-08-10 KANOVSKY STEPHEN M Director Grant or award · Restricted Stock Unit +11,336 11,336
2023-08-10 CROWTHER BRUCE K Director Grant or award · Stock Option (Right to Buy) +8,353 8,353
2023-08-10 CROWTHER BRUCE K Director Grant or award · Restricted Stock Unit +11,336 11,336
2023-08-10 TETRAULT LYNN A. Director Grant or award · Stock Option (Right to Buy) 10b5-1 +8,353 8,353
2023-08-10 TETRAULT LYNN A. Director Grant or award · Restricted Stock Unit 10b5-1 +11,336 11,336
2023-08-10 Floegel Elizabeth Director Grant or award · Stock Option (Right to Buy) +8,353 8,353
2023-08-10 Floegel Elizabeth Director Grant or award · Restricted Stock Unit +11,336 11,336
2023-08-10 Gunn Neil Director Grant or award · Stock Option (Right to Buy) +8,353 8,353
2023-08-10 Gunn Neil Director Grant or award · Restricted Stock Unit +11,336 11,336
2023-08-01 Olivo Alicia C General Counsel Shares withheld for taxes −14 40,981
2023-06-01 Sikri Vishal President Advanced Diagnostics Shares withheld for taxes −21,406 127,716
2023-05-22 TETRAULT LYNN A. Director Option exercise +1,507 $11.60 $17K 56,174
2023-05-22 TETRAULT LYNN A. Director Option exercise · Stock Option (Right to Buy) −1,507 0
2023-05-11 Smith Christopher M Chief Executive Officer Grant or award · Stock Option (Right to Buy) +269,841 269,841
2023-05-11 Smith Christopher M Chief Executive Officer Grant or award · Restricted Stock Unit +144,190 144,190
2023-05-11 Smith Christopher M Chief Executive Officer Grant or award · Performance Stock Unit +144,190 144,190
2023-05-11 Sherman Jeffrey Scott Chief Financial Officer Grant or award · Stock Option (Right to Buy) +73,016 73,016
2023-05-11 Sherman Jeffrey Scott Chief Financial Officer Grant or award · Restricted Stock Unit +39,016 39,016
2023-05-11 Sherman Jeffrey Scott Chief Financial Officer Grant or award · Performance Stock Unit +39,016 39,016
2023-05-11 Stone Warren President, Clinical Services Grant or award · Stock Option (Right to Buy) +53,969 53,969

Page 17 of 23 · 447 trades